CA2201311A1 - Systeme de gestion des prescriptions - Google Patents
Systeme de gestion des prescriptionsInfo
- Publication number
- CA2201311A1 CA2201311A1 CA002201311A CA2201311A CA2201311A1 CA 2201311 A1 CA2201311 A1 CA 2201311A1 CA 002201311 A CA002201311 A CA 002201311A CA 2201311 A CA2201311 A CA 2201311A CA 2201311 A1 CA2201311 A1 CA 2201311A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- drug
- prescription
- data
- management system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 claims abstract description 524
- 229940079593 drug Drugs 0.000 claims abstract description 516
- 230000002411 adverse Effects 0.000 claims abstract description 8
- 238000007726 management method Methods 0.000 claims description 177
- 238000011282 treatment Methods 0.000 claims description 76
- 230000008901 benefit Effects 0.000 claims description 66
- 238000000034 method Methods 0.000 claims description 57
- 238000004891 communication Methods 0.000 claims description 41
- 206010020751 Hypersensitivity Diseases 0.000 claims description 30
- 238000003860 storage Methods 0.000 claims description 30
- 230000007815 allergy Effects 0.000 claims description 29
- 230000008520 organization Effects 0.000 claims description 28
- 239000002547 new drug Substances 0.000 claims description 27
- 230000000694 effects Effects 0.000 claims description 26
- 230000006870 function Effects 0.000 claims description 24
- 238000002560 therapeutic procedure Methods 0.000 claims description 21
- 238000013474 audit trail Methods 0.000 claims description 15
- 238000010187 selection method Methods 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 13
- 238000013479 data entry Methods 0.000 claims description 12
- 230000008093 supporting effect Effects 0.000 claims description 11
- 238000002405 diagnostic procedure Methods 0.000 claims description 10
- 230000003993 interaction Effects 0.000 claims description 10
- 230000037361 pathway Effects 0.000 claims description 10
- 208000026935 allergic disease Diseases 0.000 claims description 9
- 238000013475 authorization Methods 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 238000009533 lab test Methods 0.000 claims description 8
- 230000004044 response Effects 0.000 claims description 8
- 206010013710 Drug interaction Diseases 0.000 claims description 6
- 238000011156 evaluation Methods 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 239000007894 caplet Substances 0.000 claims description 4
- 238000013500 data storage Methods 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 238000011002 quantification Methods 0.000 claims description 4
- 238000012384 transportation and delivery Methods 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 230000000474 nursing effect Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims description 3
- 239000005538 withdrawn drug Substances 0.000 claims description 3
- 239000013583 drug formulation Substances 0.000 claims description 2
- 239000011888 foil Substances 0.000 claims description 2
- 230000037406 food intake Effects 0.000 claims description 2
- 238000013507 mapping Methods 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 230000007170 pathology Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000012937 correction Methods 0.000 claims 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 2
- 238000002372 labelling Methods 0.000 claims 2
- 238000013473 artificial intelligence Methods 0.000 claims 1
- 238000004364 calculation method Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- 230000007246 mechanism Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000012552 review Methods 0.000 abstract description 18
- 239000000047 product Substances 0.000 description 27
- 230000036541 health Effects 0.000 description 24
- 230000001225 therapeutic effect Effects 0.000 description 22
- 230000008569 process Effects 0.000 description 21
- 238000012545 processing Methods 0.000 description 20
- 238000013459 approach Methods 0.000 description 11
- 238000012423 maintenance Methods 0.000 description 11
- 238000003825 pressing Methods 0.000 description 11
- 230000002354 daily effect Effects 0.000 description 9
- 230000003213 activating effect Effects 0.000 description 8
- 201000009032 substance abuse Diseases 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 206010067484 Adverse reaction Diseases 0.000 description 6
- 208000007882 Gastritis Diseases 0.000 description 6
- 230000006838 adverse reaction Effects 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 6
- 229940124597 therapeutic agent Drugs 0.000 description 6
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 5
- 229960002129 cefixime Drugs 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000002483 medication Methods 0.000 description 5
- 238000003909 pattern recognition Methods 0.000 description 5
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 4
- 208000008469 Peptic Ulcer Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- 208000011906 peptic ulcer disease Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000012550 audit Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000013523 data management Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000015976 Corneal dystrophy-perceptive deafness syndrome Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 2
- 229960004291 sucralfate Drugs 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000777300 Congiopodidae Species 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNRRHYPPQFELSF-CNYIRLTGSA-N Laninamivir Chemical compound OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(O)=O)=C[C@H](N=C(N)N)[C@H]1NC(C)=O QNRRHYPPQFELSF-CNYIRLTGSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000009092 lines of therapy Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000009512 pharmaceutical packaging Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000013515 script Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- 229940106721 tagamet Drugs 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
Abstract
Système électronique de gestion (fig 16) par radio des prescriptions fonction de l'état des malades destiné à un médecin, regroupant les dossiers des patients (10), garantissant la confidentialité (39) et fournissant: une liste des contre-indications, des informations complètes en direct sur les médicaments (50) et la littérature scientifique, des annexes sur les nouvelles associations de médicaments, des systèmes d'administration et un "réseau intelligent" de recherche à distance d'informations ( fig 16). Est également prévu un échange d'informations entre médecins par courrier électronique.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33074594A | 1994-10-28 | 1994-10-28 | |
| US08/330,939 US5737539A (en) | 1994-10-28 | 1994-10-28 | Prescription creation system |
| US330,745 | 1994-10-28 | ||
| US330,939 | 1994-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2201311A1 true CA2201311A1 (fr) | 1996-05-09 |
Family
ID=26987426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002201311A Abandoned CA2201311A1 (fr) | 1994-10-28 | 1995-10-27 | Systeme de gestion des prescriptions |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0800680A4 (fr) |
| JP (1) | JPH10508131A (fr) |
| AU (1) | AU3972295A (fr) |
| BR (1) | BR9509357A (fr) |
| CA (1) | CA2201311A1 (fr) |
| MX (1) | MX9702723A (fr) |
| WO (1) | WO1996013790A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7490049B2 (en) | 2002-03-29 | 2009-02-10 | Medco Health Solutions, Inc. | Patient oriented point of care system and method |
Families Citing this family (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210361B1 (en) | 1997-08-22 | 2001-04-03 | Deka Products Limited Partnership | System for delivering intravenous drugs |
| EP0813155A1 (fr) * | 1996-06-10 | 1997-12-17 | Smithkline Beecham Corporation | Méthode et système destinés au traitement de maladies |
| US6226620B1 (en) | 1996-06-11 | 2001-05-01 | Yeong Kuang Oon | Iterative problem solving technique |
| US5976082A (en) * | 1996-06-17 | 1999-11-02 | Smithkline Beecham Corporation | Method for identifying at risk patients diagnosed with congestive heart failure |
| DE19627464A1 (de) * | 1996-07-08 | 1998-01-15 | Siemens Ag | Prozeßautomatisierungssystem |
| US5924074A (en) * | 1996-09-27 | 1999-07-13 | Azron Incorporated | Electronic medical records system |
| US5980078A (en) * | 1997-02-14 | 1999-11-09 | Fisher-Rosemount Systems, Inc. | Process control system including automatic sensing and automatic configuration of devices |
| EP0965095A1 (fr) * | 1997-03-03 | 1999-12-22 | University Of Florida | Procede et systeme de prescription et de distribution interactives de medicaments dans des etudes medicales |
| GB2325760A (en) * | 1997-05-28 | 1998-12-02 | Kenshodo Pharmaceutical Limite | Computer-aided prescription of herb medicines |
| WO1999010829A1 (fr) * | 1997-08-22 | 1999-03-04 | Deka Products Limited Partnership | Systeme de sante et procede de saisie d'ordonnances medicales |
| US6622036B1 (en) * | 2000-02-09 | 2003-09-16 | Cns Response | Method for classifying and treating physiologic brain imbalances using quantitative EEG |
| US6915265B1 (en) | 1997-10-29 | 2005-07-05 | Janice Johnson | Method and system for consolidating and distributing information |
| CA2255291A1 (fr) * | 1997-12-08 | 1999-06-08 | Kopel H. Cohen | Systeme automatise de commande de medicaments prescrits axe sur base de donnees |
| EP0923040A3 (fr) * | 1997-12-12 | 2002-01-02 | Texas Instruments Inc. | Système d'information digitale et dispositif portable pour ledit |
| AU2673599A (en) * | 1998-02-27 | 1999-09-15 | Thomas L. Kapp | Pharmacy drug management system providing patient specific drug dosing, drug interaction analysis, order generation, and patient data matching |
| US6024699A (en) | 1998-03-13 | 2000-02-15 | Healthware Corporation | Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients |
| US6148297A (en) * | 1998-06-01 | 2000-11-14 | Surgical Safety Products, Inc. | Health care information and data tracking system and method |
| US6045501A (en) | 1998-08-28 | 2000-04-04 | Celgene Corporation | Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| WO2001037138A2 (fr) | 1999-11-15 | 2001-05-25 | Walgreens Co. | Dispositif et procede permettant d'acceder a des informations pharmaceutiques et de commander des ordonnances |
| US6947900B2 (en) * | 2000-01-06 | 2005-09-20 | Drugstore.Com | Method and apparatus for automatic product listing |
| WO2001075770A2 (fr) * | 2000-03-31 | 2001-10-11 | Disease Management Systems, Inc. | Systeme de gestion de medication par le web |
| JP3984000B2 (ja) * | 2000-05-31 | 2007-09-26 | 株式会社東芝 | 生産システム及び生産方法 |
| US9135393B1 (en) | 2000-08-02 | 2015-09-15 | Smiths Medical Asd, Inc. | Processing program data for medical pumps |
| US6315720B1 (en) * | 2000-10-23 | 2001-11-13 | Celgene Corporation | Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug |
| JPWO2002046989A1 (ja) * | 2000-12-07 | 2004-04-08 | 岩崎 誠二 | 取扱い情報登録中継システム |
| US6983423B2 (en) | 2000-12-22 | 2006-01-03 | Epic Systems Corporation | Electronic system for collecting and communicating clinical order information in an acute care setting |
| EP1381407A2 (fr) | 2000-12-29 | 2004-01-21 | Medtronic, Inc. | Techniques de regulation et de surveillance de la non-conformite pour un dispositif medical implantable |
| US6799149B2 (en) | 2000-12-29 | 2004-09-28 | Medtronic, Inc. | Therapy management techniques for an implantable medical device |
| US7072725B2 (en) | 2001-03-26 | 2006-07-04 | Medtronic, Inc. | Implantable therapeutic substance infusion device configuration system |
| US6879970B2 (en) | 2001-04-02 | 2005-04-12 | Invivodata, Inc. | Apparatus and method for prediction and management of subject compliance in clinical research |
| US7873589B2 (en) | 2001-04-02 | 2011-01-18 | Invivodata, Inc. | Operation and method for prediction and management of the validity of subject reported data |
| US8533029B2 (en) | 2001-04-02 | 2013-09-10 | Invivodata, Inc. | Clinical monitoring device with time shifting capability |
| US8065180B2 (en) | 2001-04-02 | 2011-11-22 | invivodata®, Inc. | System for clinical trial subject compliance |
| JP4759163B2 (ja) * | 2001-05-10 | 2011-08-31 | 株式会社湯山製作所 | 調剤制御システム及び調剤制御方法 |
| JP2003099535A (ja) * | 2001-09-21 | 2003-04-04 | Abc Drug & Pharmacare:Kk | 薬物動態シュミレーション情報提供システム |
| JP2003099536A (ja) * | 2001-09-25 | 2003-04-04 | Higashi Nihon Medicom Kk | 移動電子薬歴管理システム |
| JP4234342B2 (ja) * | 2001-12-26 | 2009-03-04 | パナソニック株式会社 | 部品実装装置の部品実装動作支援システム及び方法 |
| US8321236B2 (en) | 2002-02-01 | 2012-11-27 | Walgreen Co. | Method and apparatus for prescription processing |
| JP4150524B2 (ja) | 2002-02-13 | 2008-09-17 | 株式会社リコー | 生産管理方法及び生産管理プログラム |
| CN1669036A (zh) * | 2002-05-16 | 2005-09-14 | 斯科特实验室公司 | 用于镇静和止痛系统的用户授权系统和方法 |
| US7968569B2 (en) | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| USRE48890E1 (en) | 2002-05-17 | 2022-01-11 | Celgene Corporation | Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation |
| US7890350B1 (en) | 2002-06-11 | 2011-02-15 | Epocrates, Inc. | Method for generating and transmitting prescription renewal request information |
| JP2004110532A (ja) * | 2002-09-19 | 2004-04-08 | Shinkichi Himeno | 医療上の処方作成システム |
| US8404716B2 (en) | 2002-10-15 | 2013-03-26 | Celgene Corporation | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
| US11116782B2 (en) | 2002-10-15 | 2021-09-14 | Celgene Corporation | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
| US7283653B2 (en) * | 2002-11-26 | 2007-10-16 | Siemens Aktiengesellschaft | Method and system for supporting the evaluation of a picture of an eye |
| CA2509787A1 (fr) * | 2002-12-12 | 2004-06-24 | Mdg Medical, Inc. | Systeme d'administration de medicaments |
| JP2005049962A (ja) * | 2003-07-30 | 2005-02-24 | Fujitsu Ltd | オーダ発行方法、オーダ発行プログラム及びオーダ発行装置 |
| EP1528500A1 (fr) * | 2003-10-28 | 2005-05-04 | Chhabra International Ltd | Système et méthode électroniques d'ordonnance |
| AU2004296794B2 (en) * | 2003-12-04 | 2011-02-03 | Smiths Medical Asd, Inc. | Programming medical pumps with electronic standing order template |
| US8954336B2 (en) | 2004-02-23 | 2015-02-10 | Smiths Medical Asd, Inc. | Server for medical device |
| JP4615255B2 (ja) * | 2004-05-31 | 2011-01-19 | エムエム・ホールディングス株式会社 | 医療情報アクセス管理システムならびに同システムにおけるアクセス権限管理方法 |
| US7801642B2 (en) | 2004-08-18 | 2010-09-21 | Walgreen Co. | System and method for checking the accuracy of a prescription fill |
| US8914298B1 (en) | 2004-10-01 | 2014-12-16 | Edge Medical Properties, Llc | System and method for integrated verification and assembly of multi-script pouches into a housing container |
| US8266878B2 (en) | 2004-10-01 | 2012-09-18 | Edge Medical Properties, Llc | System and method for verifying and assembling a multiple prescription package |
| US9710866B2 (en) | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
| US9141764B2 (en) | 2010-11-12 | 2015-09-22 | Edge Medical Properties, Llc | System and method for online integrated multiple tablet ordering |
| US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
| US8074426B2 (en) | 2005-09-30 | 2011-12-13 | Edge Medical, Llc | Multiple prescription package and method for filling the package |
| US9015058B2 (en) | 2004-10-01 | 2015-04-21 | Edge Medical Properties, Llc | Matrix based dosage scheduling |
| US9245304B2 (en) | 2004-10-01 | 2016-01-26 | Edge Medical Properties, Llc | Manufacturing separable pouches with a center cut blade |
| US8146747B2 (en) | 2004-10-01 | 2012-04-03 | Edge Medical Properties, Llc | Tablet dispensing container |
| US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
| US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
| US8972288B2 (en) | 2004-10-01 | 2015-03-03 | Edge Medical Properties, Llc | System and method for online matrix-based dosage scheduling |
| US7690173B2 (en) | 2005-09-30 | 2010-04-06 | Edge Medical, Inc. | Multiple prescription production facility |
| US8123036B2 (en) | 2004-10-01 | 2012-02-28 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
| US8789700B2 (en) | 2004-10-01 | 2014-07-29 | Edge Medical Properties, Llc | System and method for communicating and inspecting a multiple tablet order |
| WO2006056002A1 (fr) * | 2004-11-26 | 2006-06-01 | Iba Health Limited | Systeme de gestion de medication prescrite a un patient |
| JP2006318254A (ja) * | 2005-05-13 | 2006-11-24 | Rishi Ro | 自動在庫管理システム |
| US7403123B2 (en) * | 2005-09-30 | 2008-07-22 | General Electric Company | Method and apparatus for displaying a patient worklist |
| US7734478B2 (en) | 2005-10-18 | 2010-06-08 | Walgreen Co. | Method and apparatus for inter-pharmacy workload balancing using resource function assignments |
| US7765108B2 (en) | 2005-10-18 | 2010-07-27 | Walgreen Co. | Method and apparatus for inter-pharmacy workload balancing |
| KR20070053601A (ko) * | 2005-11-21 | 2007-05-25 | 김용우 | 약품 관리 시스템 및 방법 |
| US20080126969A1 (en) | 2006-08-03 | 2008-05-29 | Blomquist Michael L | Interface for medical infusion pump |
| US8435206B2 (en) | 2006-08-03 | 2013-05-07 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
| US8858526B2 (en) * | 2006-08-03 | 2014-10-14 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
| US8965707B2 (en) | 2006-08-03 | 2015-02-24 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
| US8149131B2 (en) | 2006-08-03 | 2012-04-03 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
| US8037052B2 (en) * | 2006-11-22 | 2011-10-11 | General Electric Company | Systems and methods for free text searching of electronic medical record data |
| US9760677B2 (en) | 2009-04-29 | 2017-09-12 | Onemednet Corporation | Methods, systems, and devices for managing medical images and records |
| US9171344B2 (en) | 2007-10-30 | 2015-10-27 | Onemednet Corporation | Methods, systems, and devices for managing medical images and records |
| US8380531B2 (en) | 2008-07-25 | 2013-02-19 | Invivodata, Inc. | Clinical trial endpoint development process |
| JP2010035885A (ja) * | 2008-08-06 | 2010-02-18 | Ricoh Co Ltd | 情報記録媒体及び服薬支援システム |
| US7941325B2 (en) | 2008-11-14 | 2011-05-10 | Walgreen Co. | System and method of using a non-retail central filling facility to process pharmacy product prescriptions in a pharmacy retail network |
| EP4582105A3 (fr) | 2009-05-19 | 2025-10-08 | Celgene Corporation | Formulations de 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| WO2012019004A1 (fr) * | 2010-08-04 | 2012-02-09 | NextGen Management LLC | Système et procédure de fourniture de prescription électronique |
| EP2609546A1 (fr) * | 2010-08-23 | 2013-07-03 | Koninklijke Philips Electronics N.V. | Affectation de cas à des évaluateurs de cas sur la base de profils d'évaluateur dynamiques |
| US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
| US10276054B2 (en) | 2011-11-29 | 2019-04-30 | Eresearchtechnology, Inc. | Methods and systems for data analysis |
| DK2870072T3 (en) | 2012-07-05 | 2017-12-04 | P C O A Devices Ltd | medicine dispensers |
| BR112015002014B1 (pt) | 2012-07-30 | 2020-12-15 | P.C.O.A. Devices Ltd | Receptáculo para conter e distribuir pílulas medicinais sólidas e uso do mesmo |
| WO2014027661A1 (fr) * | 2012-08-13 | 2014-02-20 | 株式会社 東芝 | Dispositif de création de dossier médical électronique et système de création de dossier médical électronique |
| CN105073159A (zh) | 2013-01-28 | 2015-11-18 | 史密斯医疗Asd公司 | 用药安全设备及方法 |
| IL233295B (en) | 2014-06-22 | 2019-11-28 | Ilan Paz | A control pill dispensing system |
| PL3182996T3 (pl) | 2014-08-22 | 2023-04-17 | Celgene Corporation | Sposoby leczenia szpiczaka mnogiego związkami immunomodulującymi w kombinacji z przeciwciałami |
| IL238387B (en) | 2015-04-20 | 2019-01-31 | Paz Ilan | Drug dispenser release mechanism |
| US10294450B2 (en) | 2015-10-09 | 2019-05-21 | Deka Products Limited Partnership | Fluid pumping and bioreactor system |
| US11501861B2 (en) * | 2015-10-14 | 2022-11-15 | David Alan Finkelstein | System and method to access casualty health information in an emergency situation |
| JP6918810B2 (ja) | 2015-10-15 | 2021-08-11 | ドセントアールエックス エルティーディーＤｏｓｅｎｔｒｘ Ｌｔｄ | 画像認識に基づく製剤ディスペンサ |
| WO2017077529A1 (fr) | 2015-11-02 | 2017-05-11 | P.C.O.A. | Contenants de distribution de formes pharmaceutiques orales pouvant être avancés et verrouillés |
| US10241703B2 (en) | 2016-06-21 | 2019-03-26 | International Business Machines Corporation | Multivolume group management |
| US11299705B2 (en) | 2016-11-07 | 2022-04-12 | Deka Products Limited Partnership | System and method for creating tissue |
| JP2018081527A (ja) * | 2016-11-17 | 2018-05-24 | きりんカルテシステム株式会社 | 電子カルテシステム |
| JP2018081528A (ja) * | 2016-11-17 | 2018-05-24 | きりんカルテシステム株式会社 | 電子カルテシステム |
| US10093647B1 (en) | 2017-05-26 | 2018-10-09 | Celgene Corporation | Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof |
| US20180357387A1 (en) * | 2017-06-07 | 2018-12-13 | Tracelink, Inc. | Dynamic full product lifecycle pharmaceutical data distribution |
| US10093648B1 (en) | 2017-09-22 | 2018-10-09 | Celgene Corporation | Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of use thereof |
| US10093649B1 (en) | 2017-09-22 | 2018-10-09 | Celgene Corporation | Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof |
| CN110752001A (zh) * | 2019-05-05 | 2020-02-04 | 浙江亿诚智能科技有限公司 | 一种中药处方自动调剂取药方法及存储介质 |
| US11886605B2 (en) * | 2019-09-30 | 2024-01-30 | Red Hat, Inc. | Differentiated file permissions for container users |
| JP6741321B1 (ja) * | 2019-10-30 | 2020-08-19 | 株式会社プレシジョン | 薬剤例検索装置、薬剤例検索方法及び薬剤例検索プログラム |
| JP7760232B2 (ja) * | 2020-01-27 | 2025-10-27 | ニプロ株式会社 | 生体情報データ共有システム |
| US20210304859A1 (en) * | 2020-03-27 | 2021-09-30 | Nariman Bharucha | Cloud-based medical record management system with patient control |
| JP7738415B2 (ja) * | 2021-06-24 | 2025-09-12 | グローリー株式会社 | 処方箋処理装置、処方箋処理システムおよび処方箋処理方法 |
| JP2024018567A (ja) * | 2022-07-29 | 2024-02-08 | グローリー株式会社 | 精算処理システム、精算処理装置及び精算処理方法 |
| WO2025197913A1 (fr) * | 2024-03-18 | 2025-09-25 | テルモ株式会社 | Programme informatique, dispositif de traitement d'informations et procédé de traitement d'informations |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US480899A (en) * | 1892-08-16 | Electrical measuring-instrument | ||
| US5072383A (en) * | 1988-11-19 | 1991-12-10 | Emtek Health Care Systems, Inc. | Medical information system with automatic updating of task list in response to entering orders and charting interventions on associated forms |
| US5084828A (en) * | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
| US5065315A (en) * | 1989-10-24 | 1991-11-12 | Garcia Angela M | System and method for scheduling and reporting patient related services including prioritizing services |
| DE4023785A1 (de) * | 1990-07-26 | 1992-01-30 | Mueller & Sebastiani Elek Gmbh | System zur speicherung, bereitstellung und aktualisierung von festen und/oder variablen patienten- und behandlungsdaten |
| JPH04120651A (ja) * | 1990-09-12 | 1992-04-21 | Toshiba Corp | 医療情報処理システム |
| JP3074535B2 (ja) * | 1991-02-21 | 2000-08-07 | 株式会社日立製作所 | 医療情報提供システム |
| US5299121A (en) * | 1992-06-04 | 1994-03-29 | Medscreen, Inc. | Non-prescription drug medication screening system |
| JP3100777B2 (ja) * | 1992-08-31 | 2000-10-23 | 株式会社東芝 | 病院用診断支援装置 |
| JPH0678885A (ja) * | 1992-09-02 | 1994-03-22 | Toshiba Corp | 処方監査システム |
| JPH06187383A (ja) * | 1992-12-21 | 1994-07-08 | Hitachi Ltd | 院外処方箋発行システム |
| JPH06231151A (ja) * | 1993-01-29 | 1994-08-19 | Sanyo Electric Co Ltd | 医薬分業管理システム |
| JPH06259454A (ja) * | 1993-03-03 | 1994-09-16 | Toshiba Corp | 医療総合情報システム |
-
1995
- 1995-10-27 CA CA002201311A patent/CA2201311A1/fr not_active Abandoned
- 1995-10-27 AU AU39722/95A patent/AU3972295A/en not_active Abandoned
- 1995-10-27 MX MX9702723A patent/MX9702723A/es not_active IP Right Cessation
- 1995-10-27 EP EP95937691A patent/EP0800680A4/fr not_active Withdrawn
- 1995-10-27 BR BR9509357A patent/BR9509357A/pt not_active Application Discontinuation
- 1995-10-27 WO PCT/US1995/014118 patent/WO1996013790A1/fr not_active Ceased
- 1995-10-27 JP JP8514835A patent/JPH10508131A/ja not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7490049B2 (en) | 2002-03-29 | 2009-02-10 | Medco Health Solutions, Inc. | Patient oriented point of care system and method |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0800680A1 (fr) | 1997-10-15 |
| EP0800680A4 (fr) | 1998-08-12 |
| AU3972295A (en) | 1996-05-23 |
| MX9702723A (es) | 1998-04-30 |
| BR9509357A (pt) | 1997-12-30 |
| WO1996013790A1 (fr) | 1996-05-09 |
| JPH10508131A (ja) | 1998-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7072840B1 (en) | Prescription management system | |
| US5737539A (en) | Prescription creation system | |
| US7574370B2 (en) | Prescription management system | |
| US7606723B2 (en) | Computerized prescription system for gathering and presenting information relating to pharmaceuticals | |
| US20100161353A1 (en) | Prescription management system | |
| CA2201311A1 (fr) | Systeme de gestion des prescriptions | |
| US12293810B2 (en) | System and method to facilitate interoperability of health care modules | |
| US6988075B1 (en) | Patient-controlled medical information system and method | |
| US20110119092A1 (en) | Electronic health management system | |
| US20020010595A1 (en) | Web-based medication management system | |
| US20090138281A1 (en) | Patient-controlled medical information system and method | |
| WO2003040864A2 (fr) | Trousse portable de renseignements medicaux personnels | |
| JP2004535643A (ja) | 薬剤−患者情報システム | |
| Jones et al. | Utilizing big data to provide better health at lower cost | |
| JP4583911B2 (ja) | 薬品の安全性確認支援方法、安全性確認支援システム、およびプログラム | |
| JP2004118351A (ja) | 医薬品検索情報提供システム | |
| US20120245956A1 (en) | Pharmacy-based data transfer methodology | |
| US20050246203A1 (en) | Crucial and significant (C&S) patient information management and display | |
| Kakalelis | Investigations and solutions for safer medication in healthcare | |
| Darr | Nexus: Electronic Medical Records: The Future—At Some Point | |
| Mendis et al. | Electronic patient records-the reality | |
| Morgan | Identifying and understanding clinical processes | |
| Dick et al. | The Computer-Based Patient Record: Meeting Health Care Needs | |
| Dick et al. | Computer-based patient record technologies | |
| Oosterwijk | Hospital Information Systems, Radiology Information Systems, and Electronic Medical Records |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 19991027 |